[Characteristic of the causative agents of acute pneumonia isolated from patients treated with antibiotics].
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000302:isolation & purification*; D002701:Chloramphenicol / Q000494:pharmacology; D002751:Chlortetracycline / Q000494:pharmacology; D003864:Depression, Chemical; D013293:Enterococcus faecalis / Q000187:drug effects*; D004917:Erythromycin / Q000494:pharmacology; D015643:Erythromycin Ethylsuccinate / Q000494:pharmacology; D005260:Female; D005664:Furazolidone / Q000494:pharmacology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000494:pharmacology; D009582:Nitrofurantoin / Q000494:pharmacology; D009827:Oleandomycin / Q000494:pharmacology; D010118:Oxytetracycline / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D011014:Pneumonia / Q000382:microbiology*; D011113:Polymyxins / Q000494:pharmacology; D012310:Ristocetin / Q000494:pharmacology; D013210:Staphylococcus / Q000187:drug effects*; D013291:Streptococcus / Q000187:drug effects*; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014556:Urine / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D010406:Penicillins; D011113:Polymyxins; D015643:Erythromycin Ethylsuccinate; D012310:Ristocetin; D005664:Furazolidone; D004917:Erythromycin; D002701:Chloramphenicol; D009582:Nitrofurantoin; D013752:Tetracycline; D009355:Neomycin; D009827:Oleandomycin; D010400:Penicillin G; D002751:Chlortetracycline; D010118:Oxytetracycline; D013307:Streptomycin
Karakteristika vozbuditeleĭ ostrykh pnevooniĭ, vydelennykh ot bol'nykh, lechennykh antibiotikami.